|
Video: What is a Stock Split?
|
|
Oragenics is focused on developing antibiotics against infectious disease and developing treatments for oral mucositis. Co. is developing AG013, an oral rinsing solution system designed to deliver human Trefoil Factor 1 to protect and regenerate damaged mucosal lining of the oral cavity in connection with the treatment of Oral Mucositis and a product candidate, OG716, as an antibiotic, as well as other homolog antibiotic product candidates. Co.'s other product candidates include a weight loss candidate, LPT3-04, and a topical treatment to prevent dental carries which it refers to as SMaRT Replacement Therapy. According to our OGEN split history records, Oragenics has had 2 splits. | |
|
Oragenics (OGEN) has 2 splits in our OGEN split history database. The first split for OGEN took place on January 22, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of OGEN owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 100 share position following the split. OGEN's second split took place on January 23, 2023. This was a 1 for 60 reverse split, meaning for each 60 shares of OGEN owned pre-split, the shareholder now owned 1 share. For example, a 100 share position pre-split, became a 1.66666666666667 share position following the split.
When a company such as Oragenics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the OGEN split history from start to finish, an original position size of 1000 shares would have turned into 1.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Oragenics shares, starting with a $10,000 purchase of OGEN, presented on a split-history-adjusted basis factoring in the complete OGEN split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$1,158.00 |
|
End price/share: |
$1.09 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.91% |
|
Average Annual Total Return: |
-50.19% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$9.42 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
01/22/2018 | 1 for 10 | 01/23/2023 | 1 for 60 |
|
|